Twist Bioscience Corp TWST
News
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A